Announcing Riskified’s $165 Million Funding Round

Posted in Cybersecurity, Israel, Retail, Risk Management, Startup Nation, Startups, Technology, Tel Aviv, Venture Capital

Congratulations to Riskified on their Series E funding round of $165 million! Greenberg Traurig is proud to have represented an institutional investor in this transaction, and excited to have been part of this incredible achievement.

For more details, please click here.

The Israel Hotel Investment Summit: Take Five!

Posted in Event, Global, Hospitality, Israel, Real Estate, Startups, Tel Aviv, Venture Capital

On Nov. 20-21, 2019, Greenberg Traurig participated in and sponsored the Israel Hotel Investment Summit in Tel Aviv, Israel. Washington, D.C. office Shareholder and Hospitality Practice Co-Chair Nelson Migdal joined a panel, together with representatives of leading international hotel brands, on the benefits of international brand penetration into the Israel hotel market, as well as legal structuring and operational models for hotels in Israel. Attended by more than 200 professionals from Europe, the United States, and Israel, the conference demonstrated Israel’s status as a major international hospitality destination. Tel Aviv office Managing Shareholder Joey Shabot (M&A), Shareholder Lawrence Sternthal (Real Estate), and Associate Saar Warner-Lipton (Real Estate) also attended the summit.

Here are the top five highlights: Continue Reading

Adam Snukal Discusses Effects of Privacy Laws on Israeli-Based Call Center Technology Providers

Posted in compliance, Cybersecurity, Data protection, Israel, Privacy and Data Security, Technology, Tel Aviv, telecommunications

On Nov. 25, 2019, GT Shareholder Adam Snukal participated in a fire-side chat at NICE’s Annual Personal Connections Elevated Israel Conference. The discussion focused on the effects of the GDPR, CCPA, and other privacy laws on Israeli-based call center technology providers that operate in an increasingly global arena. Continue Reading

Amadeus leads a $9.8M investment round in Refundit to digitalize VAT refunds for travelers worldwide

Posted in Firm News, Israel, Startup Nation, Startups, Venture Capital

Congratulations to our long-standing client Amadeus upon its investment in Refundit, an Israeli startup which is developing a mobile solution to make it easier for travelers to get their VAT money back.

For more details, please click here.

U.S. House Passes Bill That Would Require Disclosure of Beneficial Owners of U.S. Corporations and Limited Liability Companies

Posted in Corporate

A newly approved Bill could significantly increase disclosure requirements for Israelis invested in or operating business in the U.S. The Corporate Transparency Act of 2019 would require that the identities (including addresses and passport information) of the “beneficial owners” of US LLC’s or corporations be reported. Updated information would need to provided annually. While similar requirements are the norm in the E.U., it has until now been possible for many people to establish or invest in a U.S. entity while keeping their identity hidden. The bill, if enacted in law, would apply immediately to newly formed entities, with existing companies having two years to comply.

Click here to read the full GT alert prepared by Carl A. Fornaris (Shareholder), Marina Olman-Pal (Of Counsel), and Anthony J. Fernandez (Associate) of GT’s Miami office.

^ Attorneys in the Tel Aviv office do not practice Israeli law.

2 Recent Cases Impacting False Claims Act Litigation and Investigations Deserve the Attention of Health Care Providers and Private Equity Investors

Posted in Health Care & FDA

The United States Attorney’s Office for the Southern District of Florida announced on Sept. 19, 2019, that it settled a qui tam False Claims Act case in which a private equity firm was a named defendant. See United States ex rel. Medrano and Lopez v. Diabetic Care Rx LLC, d/b/a Patient Care America, et al., No. 15-CV-62617 (S.D. Fla.). On Sept. 9, 2019, in a win for hospice and other health care providers, the Eleventh Circuit Court of Appeals ruled in United States v. Aseracare, Inc., — F.3d — (11th Cir. 2019) that a mere difference in medical judgment cannot rise to a false statement under the False Claims Act. This case involved hospice care and whether the defendant improperly certified patients as being terminally ill so as to meet the Medicare requirement for hospice services.

Click here for the full GT Alert, which discusses these two cases.

Does Section 1782 Apply to Discovery in Private International Commercial Arbitration Proceedings?

Posted in Commercial Agreements, Israel, Litigation

Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration under 28 U.S.C. § 1782. Section 1782 is a powerful tool that permits litigants to obtain broad discovery in the United States for use in international arbitrations, which traditionally do not provide for or allow significant discovery. But U.S. courts have found that not all international arbitrations qualify under this statute. While courts have permitted Section 1782 to be used in connection with investor-State arbitration, they have wrestled with whether to apply the statute in the context of international arbitration between two private, commercial parties.

The statute states in pertinent part: “The district court of the district in which a person resides or is found may order him to give his testimony or statement or to produce a document or other thing for use in a proceeding in a foreign or international tribunal, . . . The order may be made pursuant to a letter rogatory issued, or request made, by a foreign or international tribunal or upon the application of any interested person and may direct that the testimony or statement be given, or the document or other thing be produced, before a person appointed by the court.”

Click here to read the full GT Alert, “Does Section 1782 Apply to Discovery in Private International Commercial Arbitration Proceedings?”

Attention New York Employers: When It Comes to Workplace Harassment, Times Are Changing

Posted in Labor & Employment

Employers have only seven weeks to ensure that all employees working in the State of New York have completed a sexual harassment prevention training program that meets the standards required by the newly amended New York Human Rights Law.  The mandatory training obligation applies to all companies, regardless of their size, and will continue to be the employer’s responsibility on an annual basis. The Law includes a number of additional new obligations for employers, including the requirement that New York employees receive a sexual harassment policy comparable to the “model” policy issued by the New York State Department of Labor.

Click here to read the full GT alert prepared by Robert H. Bernstein (Shareholder), Jerrold F. Goldberg (Shareholder), Eric B. Sigda (Shareholder), Mark D. Lurie (Of Counsel), Michael J. Slocum (Of Counsel), Noel A. Lesica (Associate), and Melanie A. Sarver (Practice Group Attorney) of GT’s New York and New Jersey offices.